Christopher T. Ritchlin

25.9k citations

347 papers · 15.3k indexed · 9 hit papers · h-index 61

Impact in

Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 277
- Spondyloarthritis Studies and Treatments 217
- Rheumatoid Arthritis Research and Therapies 159
- Systemic Lupus Erythematosus Research 18
Hematology 143
- Autoimmune and Inflammatory Disorders Research 142

Co-authors: Dafna D. Gladman Edward M. Schwarz Philip J. Mease Robert A. Colbert Arthur Kavanaugh Iain B. McInnes Alice B. Gottlieb Sally A. Haas-Smith
Journals: Annals of the Rheumatic Diseases (68 papers)The Journal of Rheumatology (48 papers)Lara D. Veeken (13 papers)Current Rheumatology Reports (12 papers)Arthritis & Rheumatology (12 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Christopher T. Ritchlin

334 papers receiving 14.9k citations

Hit Papers

9 papers align trajectories log scale

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy 2024 · 42 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Frontiers in Immunology
2020 The Lancet
2019 Nature Reviews Rheumatology
2017 New England Journal of Medicine
2016 Annals of the Rheumatic Diseases
2015 The Lancet
2014 Annals of the Rheumatic Diseases
2013 The Lancet
2005 Arthritis & Rheumatism

Peers

Countries citing papers authored by Christopher T. Ritchlin

Since Specialization

Citations

This map shows the geographic impact of Christopher T. Ritchlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Ritchlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Ritchlin more than expected).

Fields of papers citing papers by Christopher T. Ritchlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Ritchlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Ritchlin. The network helps show where Christopher T. Ritchlin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher T. Ritchlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher T. Ritchlin Line = papers co-authored together Christopher T. Ritchlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD3+ immune cell endotypes are associated with PsA disease phenotype and response to advanced therapy: an integrated mass cytometry and proteomics cohort study Annals of the Rheumatic Diseases ·Lihi Eder, Stuti Dang, Stéphane Caucheteux, Xianwei Li, Gerrit van den Engh, 郭建锋, Christopher T. Ritchlin, Igor Jurišica, Vincent Piguet, Yogi Parta, Fabio Battiato	2025	0
2	Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial Nature Medicine ·Iain B. McInnes, Laura C. Coates, Philip J. Mease, Pawel Wityk, Arthur Kavanaugh, Lihi Eder, Georg Schett, Alan Kivitz, Dennis McGonagle, Chris Curtin, A. Godwood, M. Scolieri-Masella, Kristian Reich, Christopher T. Ritchlin, Joseph F. Merola	2025	1
3	Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) Seminars in Arthritis and Rheumatism ·宏道岩木, Changyong Feng, Ashley Frazer‐Abel, Roberta Gonçalves Marangoni, Ramil Zagidullin, William C. Nichols, V. Michael Holers, Christopher T. Ritchlin, R. James White, Benjamin D. Korman	2024	0
4	Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis Clinical Rheumatology ·Proton Rahman, Iain B. McInnes, Atul Deodhar, Georg Schett, Phillip J. Mease, M. Shawi, J. Daniel, Jonathan Sherlock, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Christopher T. Ritchlin, Dennis McGonagle	2024	0
5	Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis Lara D. Veeken ·Dennis McGonagle, Arthur Kavanaugh, Iain B. McInnes, Lars Erik Kristensen, Joseph F. Merola, Bruce Strober, Rebecca Bolce, Jeffrey Lisse, Arthessarat Sirisa-Ard, Christophe Sapin, Christopher T. Ritchlin	2024	2
6	Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study Clinical Rheumatology ·Christopher T. Ritchlin, Philip J. Mease, Wolf‐Henning Boehncke, John Tesser, Soumya D. Chakravarty, Emmanouil Rampakakis, M. Shawi, Elena Schiopu, Joseph F. Merola, Iain B. McInnes, Atul Deodhar	2024	1
7	Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease The Journal of Rheumatology ·Beibei Chen, Laura C. Coates, Drs Forth, Sahil Koppikar, Lourdes M. Pérez-Chada, L. Puig, Alexis Ogdie, Atul Deodhar, Christopher T. Ritchlin, Samuel Hwang, Cláudia Goldenstein‐Schainberg	2024	0
8	AB1104 STRINGENT DISEASE ACTIVITY CONTROL AT 2 YEARS ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE CHARACTERISTICS IN PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY Christopher T. Ritchlin, Philip J. Mease, Wolf‐Henning Boehncke, John Tesser, Irina Rinkovec, Pieter R. Koopman Jan, M. Shawi, Elena Schiopu, Joseph F. Merola, Iain B. McInnes, Atul Deodhar	2023	2
9	769 GUSELKUMAB, AN IL-23P19 SUBUNIT-SPECIFIC MONOCLONAL ANTIBODY, BINDS CD64+ MYELOID CELLS AND POTENTLY NEUTRALIZES IL-23 PRODUCED FROM THE SAME CELLS Gastroenterology ·María T. Abreu, Raja Atreya, James G. Krueger, Kilian Eyerich, Kacey L. Sachen, Zvjezdana Janičar, Deepa Hammaker, 肖观东, Eilyn R. Lacy, Mohammad Husainy, H.J. Park, M. Merle Elloso, Christopher T. Ritchlin, Iain B. McInnes, Matthieu Allez, Anne M. Fourie	2023	0
10	Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies ACR Open Rheumatology ·Dennis McGonagle, Iain B. McInnes, Atul Deodhar, Georg Schett, M. Shawi, Soumya D. Chakravarty, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Stephen Xu, Christopher T. Ritchlin, Proton Rahman, Phillip J. Mease	2023	4
11	Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo‐Controlled Trials ACR Open Rheumatology ·Stefan Siebert, Kristen Sweet, Christopher T. Ritchlin, Elizabeth C. Hsia, Alexa P. Kollmeier, Xie L. Xu, Loqmane Seridi, Qingxuan Song, Sheng Gao, Hua Liu, Michelle Miron	2023	2
12	Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies RMD Open ·Christopher T. Ritchlin, Philip J. Mease, Wolf‐Henning Boehncke, John Tesser, Elena Schiopu, Soumya D. Chakravarty, Alexa P. Kollmeier, Xie L. Xu, M. Shawi, Syaiful Rahman, Shihong Sheng, Yanli Wang, Stephen Xu, Joseph F. Merola, Iain B. McInnes, Atul Deodhar	2022	18
13	Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis Lara D. Veeken ·Laura C. Coates, Christopher T. Ritchlin, Laure Gossec, Philip Helliwell, Proton Rahman, Alexa P. Kollmeier, Xie L. Xu, M. Shawi, Chetan S. Karyekar, 连杰, W. Noël, Shihong Sheng, Yanli Wang, Stephen Xu, Philip J. Mease	2022	11
14	Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis Lara D. Veeken ·Philip J. Mease, Iain B. McInnes, Lai‐Shan Tam, A. NWANGWU, The Honourable H.S. Patterson, Xianjie Mo, Soumya D. Chakravarty, Cynthia Wickham, Chetan S. Karyekar, Sandhya Nair, Wolf‐Henning Boehncke, Christopher T. Ritchlin	2021	42
15	Differences in oxylipin profile in psoriasis versus psoriatic arthritis Arthritis Research & Therapy ·Roxana Coras, Arthur Kavanaugh, 正一白井, O Kodl, Andri S. Siahaan, P. Sumner Osd ., Oswald Quehenberger, Christopher T. Ritchlin, Mónica Gumá	2021	16
16	Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology Current Rheumatology Reviews ·Emily Wu, Héctor Juárez Hernández, R.M. Kottmann, Christopher T. Ritchlin, Edward M. Schwarz, Homaira Rahimi	2019	23
17	GRAPPA 2018 Project Report The Journal of Rheumatology ·Niti Goel, Oliver FitzGerald, Dafna D. Gladman, Philip Helliwell, Arthur Kavanaugh, Walter P. Maksymowych, Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates	2019	6
18	Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry The Journal of Rheumatology ·Philip J. Mease, Chitra Karki, Jacqueline B. Palmer, Carol J. Etzel, Arthur Kavanaugh, Christopher T. Ritchlin, Wendi Malley, Vivian Herrera, Cheng‐Da Zhao, Jeffrey D. Greenberg	2017	19
19	Ustekinumab Improves Arthritis-Related And Skin-Related Quality Of Life In Patients With Active Psoriatic Arthritis: Patient Reported Outcomes From Randomized And Double Blinded Phase Iii Psummit I Trial Value in Health ·Arthur Kavanaugh, Iain B. McInnes, Alice B. Gottlieb, L. Puig, Proton Rahman, Christopher T. Ritchlin, Alwizar Alwizar, Zhang Yueping, Seiji Matsumoto, Aaron B. Mendelsohn, Archana Dahal	2013	1
20	Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria Data Archiving and Networked Services (DANS) ·Walter P. Maksymowych, Fāi sapphayākǭn thammachāt læ sing wǣt lǭm, Robert Landewé, Maria Carolina da Cunha de Castro Souza, Joan M. Bathon, (unknown), Vivian P. Bykerk, Mikkel Østergaard, Hilde Berner Hammer, (unknown), (unknown), Oliver FitzGerald, Christopher T. Ritchlin, Dafna D. Gladman, Philip J. Mease, (unknown), M. Backhaus, Bernard Combe, Abián Muñoz, A. Marotta	2012	2

About Christopher T. Ritchlin

Christopher T. Ritchlin is a scholar working on Rheumatology, Hematology, Immunology, Orthopedics and Sports Medicine and Immunology and Allergy, having authored 347 papers that have together received 15.3k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (217 papers), Psoriasis: Treatment and Pathogenesis (195 papers), Rheumatoid Arthritis Research and Therapies (159 papers), Autoimmune and Inflammatory Disorders Research (142 papers), Bone Metabolism and Diseases (20 papers), Systemic Lupus Erythematosus Research (18 papers), Lymphatic System and Diseases (17 papers) and Bone and Joint Diseases (14 papers). The work is most often cited by research in Rheumatology (10.1k citations), Hematology (5.4k citations), Immunology (9.6k citations), Dermatology (1.7k citations) and Orthopedics and Sports Medicine (654 citations). Christopher T. Ritchlin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Dafna D. Gladman, Edward M. Schwarz, Philip J. Mease, Robert A. Colbert, Arthur Kavanaugh, Iain B. McInnes, Alice B. Gottlieb, Sally A. Haas-Smith, Proton Rahman and David G. Hicks. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lara D. Veeken, Current Rheumatology Reports and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact